U.S. Markets closed

Bristol-Myers Squibb Company (BMY)

NYSE - Nasdaq Real Time Price. Currency in USD
Add to watchlist
Visitors trend2W10W9M
60.12-0.64 (-1.05%)
At close: 4:00PM EDT
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Performance Outlook
Previous Close60.76
Open60.83
Bid60.13 x 3100
Ask61.00 x 1100
Day's Range60.07 - 61.22
52 Week Range45.76 - 68.34
Volume7,336,812
Avg. Volume9,949,860
Market Cap135.506B
Beta (5Y Monthly)0.68
PE Ratio (TTM)N/A
EPS (TTM)-0.28
Earnings DateNov 05, 2020
Forward Dividend & Yield1.80 (2.99%)
Ex-Dividend DateOct 01, 2020
1y Target Est73.69
  • 2 Top Pharma Stocks to Buy Right Now
    Motley Fool

    2 Top Pharma Stocks to Buy Right Now

    This alone makes it worthwhile for long-term investors to consider pharma stocks. Two that I think are worth buying right now are Bristol Myers Squibb (NYSE: BMY) and Alexion Pharmaceuticals (NASDAQ: ALXN). Both drugmakers are trading at attractive valuations: Bristol Myers' forward price-to-earnings (P/E) ratio is 8, while its price-to-earnings growth (PEG) is 0.81.

  • Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus
    Zacks

    Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus

    The healthcare is expected to witness substantial earnings growth of 5.1% in the third quarter, representing the second strongest sector this earnings season.

  • Bristol Myers Announced Another Major Acquisition — But Is BMY Stock A Buy?
    Investor's Business Daily

    Bristol Myers Announced Another Major Acquisition — But Is BMY Stock A Buy?

    Bristol Myers stock has slipped this year. But acquiring Celgene has bolstered the pharmaceutical company's sales, and the pending acquisition of MyoKardia might also. So is BMY stock a buy?